AQST

Aquestive Therapeutics, Inc. AQST

$4.12 +0.18 (+4.57%)

Neutral · -0.33σ

+ Compare Open in Sniper

Mkt cap $0.5B

P/E —

Day $3.81 – $4.16

52wk $2.93 – $5.18

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

Aquestive Therapeutics, Inc. is a healthcare company listed in the US.

AQST last traded at $4.12, up 4.6% on the day; that's in the middle part of its 52-week range ($2.93–$5.18). Right now it's trading close to its recent average, with no strong stretch in either direction.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Fair-value range

$1.07 – $1.07

Verdict

Unknown

Accounting quality Weak

✓ More cash than debt
✓ Quick ratio 2.49 (antifragile)
✓ Current ratio 3.14 (antifragile)
✓ Gross margin 63% (pricing power)

⚠ Negative retained earnings
⚠ Receivables growing faster than revenue
⚠ Inventory growing faster than revenue
⚠ Stock comp 17% of revenue (heavy dilution)

Key statistics

All statistics →

AQST is a $509 million company.

Mkt cap $0.5B

P/E ttm —

Fwd P/E —

Beta —

Day range $3.81 – $4.16

52w range $2.93 – $5.18

Avg vol —

RSI(2) 82.3

ROE —

Net mgn —

FCF mgn -57.7%

Debt/Eq —

Div yld —

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Next earn —

52-week range · today's price

$2.93$5.18